Clinical Trial Update: Tramadol Extended-Release (ER) for Posttraumatic Stress Disorder (PTSD) [Phase 4]

View source ↗

Summary

Phase 4 trial update for tramadol extended-release in post-traumatic stress disorder has completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Post-traumatic Stress Disorder

Drugs mentioned

• Tramadol extended-release (tramadol)

Snippet

Sponsor: INTRuST, Post-Traumatic Stress Disorder - Traumatic Brain Injury Clinical Consortium | Conditions: Post-Traumatic Stress Disorder | Phase 4 | Status: COMPLETED | Results posted: 2022-08-31